Skip Navigation


Rheumatology Advance Access originally published online on June 14, 2007
Rheumatology 2007 46(8):1219-1220; doi:10.1093/rheumatology/kem083
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
46/8/1219    most recent
kem083v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Isenberg, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Isenberg, D. A.
Related Collections
Right arrow Health Economics
Right arrow Education
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

EDITORIALS

30 million, around 10 000 ... and 18 ... Figuring out the optimal treatment for musculoskeletal conditions in the National Health Service

D. A. Isenberg

Centre for Rheumatology Research, University College London,
Division of Medicine, Room 331, 3rd Floor, 46 Cleveland Street,
London W1T 4JF, UK.

Correspondence to: D. A. Isenberg. E-mail: d.isenberg@ucl.ac.uk

The first 10% of the full text of this article appears below.

The Independent newspaper published in the UK is fond of printing front pages consisting mostly of numbers that highlight particular aspects of the story they are covering. It certainly catches the readers’ attention. I would urge that any rheumatologist in the UK to bear in mind the figures 30 million, around 10 000 and 18 when they practice their subspecialty.

The figure of 30 million—pounds—was the number given to members of the Executive Committee of the British Society for Rheumatology involved in discussions with officials from the Department of Health in drawing up the ‘Musculoskeletal Services Framework—A Joint Responsibility: Doing It Differently’ [1]—and refers to the weekly cost to the UK of disability benefit due to musculoskeletal diseases. This huge figure, apart from being second only to psychiatric conditions amongst the subspecialties, also fails to take into account the cost of lack of productivity amongst . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?